Lv2
156 积分 2022-05-04 加入
CAR-neutrophils produced in vivo to treat glioma
12小时前
已完结
First-in-human mRNA CAR therapy: Correlative biomarker analysis from the MT-302 phase 1 study targeting TROP2 in patients with advanced epithelial tumors
1天前
已完结
108 MCY-M11, a CAR-PBMC cell product transiently expressing a mesothelin targeted mRNA CAR, exhibits desirable functional and immune phenotype attributed to sustained antitumor immunity in vitro
9天前
已完结
In Vivo Monocyte/Macrophage-Hitchhiked Intratumoral Accumulation of Nanomedicines for Enhanced Tumor Therapy
9天前
已完结
Macrophage-targeted immunocytokine leverages myeloid, T, and NK cell synergy for cancer immunotherapy
11天前
已完结
Macrophage-targeted immunocytokine leverages myeloid, T, and NK cell synergy for cancer immunotherapy
2个月前
已完结
Abstract 3136: EOS-215, a first-in-class TREM2 antagonist, designed to reprogram the tumor microenvironment and overcome resistance
2个月前
已关闭
Phase 1 study of autologous T cells bearing fully human chimeric antigen receptors targeting mesothelin in mesothelin-expressing cancers
2个月前
已关闭
Phase I study of autologous T cells bearing fully-humanized chimeric antigen receptors targeting mesothelin in mesothelin- expressing cancers (314)
2个月前
已完结
Generating potent and persistent antitumor immunity via affinity-tuned CAR-T cells targeting mesothelin
2个月前
已完结
皖公网安备34019202002308
